Research Overview: Dapoxeodin (Dapoxetine) Odin Pharmaceuticals
Dapoxeodin (Dapoxetine) is a selective serotonin reuptake inhibitor (SSRI) produced by Odin Pharmaceuticals specifically for in-vitro research applications. This short-acting SSRI compound belongs to the naphthalene derivative class and demonstrates selective inhibition of the serotonin transporter protein (SERT) in laboratory studies. Researchers at Stroid UK Shop can access this pharmaceutical-grade compound to investigate serotonergic pathways and neurotransmitter modulation mechanisms. The compound exhibits rapid onset and elimination kinetics in preclinical models, making it valuable for studying acute serotonin reuptake inhibition effects without prolonged system exposure.
Research Applications
Laboratory studies have examined dapoxetine’s effects on central nervous system serotonin regulation and its interaction with various neurotransmitter systems. Research teams investigating selective serotonin reuptake mechanisms utilise this compound to study the pharmacokinetics of short-acting SSRI activity. The compound’s unique pharmacological profile allows researchers to examine acute serotonin modulation without the extended half-life complications associated with traditional SSRI compounds. Scientists exploring neurotransmitter pathway interactions often compare dapoxetine’s effects with other research chemicals available through specialised suppliers, including selective androgen receptor modulators and peptide compounds for comprehensive neurochemical research protocols.
Technical Specifications
| Parameter | Value |
|---|---|
| Chemical Name | Dapoxetine |
| CAS Registry | 119356-77-3 |
| Molecular Formula | C₂₁H₂₃NO |
| Molecular Weight | 305.41 g/mol |
| Manufacturer | Odin Pharmaceuticals |
| Purity | Verify with supplier |
| Storage Conditions | Room temperature, dry environment |
| Classification | SSRI/Neurotransmitter modulator |
Research Compliance
This product is manufactured exclusively for in-vitro research purposes and laboratory investigations. Dapoxeodin is not intended for human consumption, therapeutic use, or any application outside controlled research environments. Research institutions must ensure proper handling protocols, waste disposal procedures, and compliance with local regulations governing research chemical use. All studies should be conducted under appropriate laboratory safety conditions with qualified research personnel. This compound is supplied for legitimate research purposes only and requires proper documentation of intended research applications.
